(Q37130033)

English

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

scientific article published on 05 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Sven Gunia

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Knut Albrecht

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Stefan Koch

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Thomas Herrmann

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Thorsten Ecke

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Volker Loy

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Jörg Linke

7

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Michael Siegsmund

8

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Matthias May

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

publication date

5 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

World Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

243-250

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

https://scigraph.springernature.com/pub.10.1007/s00345-008-0257-0

0 references

Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of neuroendocrine differentiation in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of human prostate cancer cells to neuroendocrine-like cells by interleukin-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The usefulness of Ki67 expression in the biopsy specimens, to predict the biochemical progresion of the prostate cancer after radical prostatectomy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine differentiation in prostatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine and immune mediators in prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The possible role of chromogranin A as a prognostic factor in organ-confined prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18392627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00345-008-0257-0

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37130033&oldid=2130617454"